SmartCella beviljas nytt europeiskt patent för leveransplattformen Extroducer
XyloCor and SmartCella enter into license agreement for use of the Extroducer to administer novel gene therapy XC001 to the heart
SmartCella tecknar licensavtal med XyloCor avseende Extroducer för att leverera genterapin XC001 till hjärtat
SmartCella raises EUR 50 million to accelerate growth and commercialization
SmartCella tar in 50 miljoner euro för att accelerera tillväxt och kommersialisering
Senior life science and medical specialists join SmartCella’s Board of Directors
SmartCella strengthens team with Dr Ricardo Baptista as CTO
SmartCella AB appoints Oskar Steneryd as new CFO
SmartCella obtains approval for GMP manufacturing and quality control testing of cell therapies
SmartCella strengthens team by recruiting Dr. Nina Bauer as Chief Business Officer
Let’s pioneer the future of targeted therapies together